Serum procalcitonin concentration in patients with Kawasaki disease
about
Mercury promotes catecholamines which potentiate mercurial autoimmunity and vasodilation: implications for inositol 1,4,5-triphosphate 3-kinase C susceptibility in kawasaki syndromePoint-of-care differentiation of Kawasaki disease from other febrile illnesses.Clinical usefulness of serum procalcitonin level in distinguishing between Kawasaki disease and other infections in febrile children.Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis.High Level Serum Procalcitonin Associated Gouty Arthritis Susceptibility: From a Southern Chinese Han Population.Procalcitonin levels in patients with complete and incomplete Kawasaki disease.Limited diagnostic value of procalcitonin in early diagnosis of adult onset Still's disease.The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis.Comparison of the diagnostic value of procalcitonin and C-reactive protein after hematopoietic stem cell transplantation: a systematic review and meta-analysis.Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections.Distinguishing infections vs flares in patients with systemic lupus erythematosus.Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?Evaluation of serum procalcitonin and C-reactive protein levels as biomarkers of Henoch-Schönlein purpura in pediatric patients.A novel marker procalcitonin may help stem the antibiotic overuse in emergency setting.The relationship between procalcitonin and thyroid autoantibodies in patients with autoimmune thyroiditis.
P2860
Q26824143-F3CFC42D-8559-4FF4-B2BD-9AC6B11FFBE7Q33438988-977840AF-5134-4BA8-B41E-96E1B8B62F6CQ33619503-77DE6BE3-242C-4932-8F57-1B47E44783E5Q34273276-16C9F683-5AF0-468B-B798-3495EAC5ABB1Q35693667-6C2DEC60-B93A-40CC-86EC-08873E9C1484Q37259079-482B991E-199D-4F90-A60A-C95A722DCC0BQ37385719-43985F20-2949-40E8-B324-982442BB085FQ38075467-477FEBBE-EB31-46DC-88E6-964F5FB93A63Q38079626-B685652B-990A-4304-B1AC-C82C41C4381AQ38263160-A80708BC-56E7-4B44-8212-440659FDD594Q38981689-E10FC542-71EC-4DBC-99E1-F4AC9A55541AQ40132610-49A85633-6B00-4086-BEC5-0E9B523BF897Q40500674-D12654F9-18DE-4A0F-A032-DD920AD28F95Q41719840-7BBCC5C7-2B61-434A-8702-DBC2FF140660Q41880441-5BB6CFE5-0A55-4509-A257-F5C8409087BFQ47867307-CC4272BD-D346-444E-A675-26F2A29DB6CF
P2860
Serum procalcitonin concentration in patients with Kawasaki disease
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Serum procalcitonin concentration in patients with Kawasaki disease
@ast
Serum procalcitonin concentration in patients with Kawasaki disease
@en
Serum procalcitonin concentration in patients with Kawasaki disease
@nl
type
label
Serum procalcitonin concentration in patients with Kawasaki disease
@ast
Serum procalcitonin concentration in patients with Kawasaki disease
@en
Serum procalcitonin concentration in patients with Kawasaki disease
@nl
prefLabel
Serum procalcitonin concentration in patients with Kawasaki disease
@ast
Serum procalcitonin concentration in patients with Kawasaki disease
@en
Serum procalcitonin concentration in patients with Kawasaki disease
@nl
P2093
P3181
P1433
P1476
Serum procalcitonin concentration in patients with Kawasaki disease
@en
P2093
Akihiro Morikawa
Hirokazu Kimura
Hisanori Minakami
Kunihisa Kozawa
Masahiko Kato
Takeshi Tomomasa
Yasunori Okada
Yoshinari Inoue
P304
P3181
P356
10.1016/J.JINF.2003.08.002
P407
P577
2004-02-01T00:00:00Z